Diary - News
All news Erytech raises €30 million
Erytech Pharma, the french biopharmaceutical company that develops innovate "tumor starvation" treatments for acute leukemia and other oncology indications with unmet medical need, announces today the successful completion of a capital increase for a total amount of €30 million.
